12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Altrazeal Silver regulatory update

Uluru submitted a 510(k) application to FDA for its Altrazeal Silver to treat...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >